The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid

Jason R Thomas1, Johna C B DeNap, Margaret L Wong

  • 1Department of Chemistry, Roger Adams Laboratory, University of Illinois, Urbana, Illinois 61801, USA.

Biochemistry
|May 4, 2005
PubMed

Insights

Small molecules can mimic plasmid incompatibility to eliminate antibiotic resistance plasmids from bacteria. This approach resensitizes bacteria to antibiotics by targeting key RNA replication control elements.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Drug Discovery

Background:

  • Antibiotic resistance is a major clinical challenge, often mediated by plasmids.
  • Plasmid incompatibility is a natural mechanism for plasmid elimination in bacteria.

Purpose of the Study:

  • To validate and substantiate the use of small molecules to mimic plasmid incompatibility.
  • To investigate the potential of targeting RNA replication control elements for plasmid elimination.

Main Methods:

  • Determined dissociation constants and stoichiometry of aminoglycoside binding to IncB plasmid stem-loop I (SLI) RNA.
  • Assessed the ability of small molecules to induce plasmid loss in vivo.
  • Correlated RNA binding with plasmid elimination efficacy.

Main Results:

  • 12 aminoglycosides were characterized for their binding to SLI RNA.
  • Compounds binding to SLI RNA induced measurable plasmid loss in vivo.
  • Compounds not binding to SLI RNA failed to induce plasmid loss.

Conclusions:

  • Small molecules can effectively mimic plasmid incompatibility by targeting essential RNA replication elements.
  • Targeting RNA replication control offers a promising strategy for inducing plasmid loss.
  • This approach can lead to the resensitization of bacteria to antibiotics.

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...